Fenglong Xie

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Electronic Health Record

Clinical Decision Support

Affordable Care Act

Cardiovascular Disease

Top Venues

Pharmacoepidemiology and drug safety

JMIR human factors

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy Beukelman, Lang Chen, Narender Annapureddy, Jim Oates, Megan E B Clowse, Millie Long, Michael D Kappelman, Rennie L Rhee, Peter A Merkel, William Benjamin Nowell, Fenglong Xie, Cassie Clinton, Jeffrey R Curtis
Using Pooled Electronic Health Records Data to Conduct Pharmacoepidemiology Safety Studies: Challenges and Lessons Learned. Pharmacoepidemiology and drug safety (2023)
William Benjamin Nowell, Jeffrey R Curtis, Hong Zhao, Fenglong Xie, Laura Stradford, David Curtis, Kelly Gavigan, Jessica Boles, Cassie Clinton, Ilya Lipkovich, Shilpa Venkatachalam, Amy Calvin, Virginia S Hayes
Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study. JMIR human factors 10 (2023)
Rachel W Galvao, Jeffrey R Curtis, Leslie R Harrold, Qufei Wu, Fenglong Xie, Michael D George
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis. Pharmacoepidemiology and drug safety (2023)
Fenglong Xie, Lisandro D Colantonio, Jeffrey R Curtis, Meredith L Kilgore, Emily B Levitan, Keri L Monda, Monika M Safford, Ben Taylor, Mark Woodward, Paul Muntner
Development of algorithms for identifying fatal cardiovascular disease in Medicare claims. Pharmacoepidemiology and drug safety 27 (7) (2018)